1. Home
  2. ASPN vs ADCT Comparison

ASPN vs ADCT Comparison

Compare ASPN & ADCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Aspen Aerogels Inc.

ASPN

Aspen Aerogels Inc.

HOLD

Current Price

$5.36

Market Cap

447.5M

ML Signal

HOLD

Logo ADC Therapeutics SA

ADCT

ADC Therapeutics SA

HOLD

Current Price

$3.16

Market Cap

445.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ASPN
ADCT
Founded
2001
2011
Country
United States
Switzerland
Employees
854
N/A
Industry
RETAIL: Building Materials
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
447.5M
445.2M
IPO Year
2011
2019

Fundamental Metrics

Financial Performance
Metric
ASPN
ADCT
Price
$5.36
$3.16
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
4
Target Price
$4.25
$7.75
AVG Volume (30 Days)
2.0M
1.1M
Earning Date
05-07-2026
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
30.86
EPS
N/A
N/A
Revenue
$271,103,000.00
$81,357,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$50.03
$66.49
P/E Ratio
N/A
N/A
Revenue Growth
N/A
14.85
52 Week Low
$2.30
$1.83
52 Week High
$9.78
$4.98

Technical Indicators

Market Signals
Indicator
ASPN
ADCT
Relative Strength Index (RSI) 67.31 28.02
Support Level $3.01 $3.11
Resistance Level $7.46 $4.73
Average True Range (ATR) 0.43 0.22
MACD 0.13 -0.06
Stochastic Oscillator 72.50 3.00

Price Performance

Historical Comparison
ASPN
ADCT

About ASPN Aspen Aerogels Inc.

Aspen Aerogels Inc is an aerogel technology company that designs, develops, and manufactures high-performance aerogel insulation used in the energy industrial and sustainable insulation markets. The company also conducts research and development related to aerogel technology, supported by funding from several agencies of the United States of America government and other institutions in the form of research and development contracts. It is engaged in two operating segment Energy Industrial and Thermal Barrier. Geographically, it operates in the U.S. and also has a presence in other International countries. It generates the majority of its revenue from the Thermal Barrier segment and the United States market. Some of its products include Pyrogel XTE, Cryogel Z, Spaceloft Subsea, and others.

About ADCT ADC Therapeutics SA

ADC Therapeutics SA is a commercial-stage oncology-focused biotechnology company. It is involved in the development of antibody-drug conjugates for patients suffering from hematological malignancies and solid tumors. The company's FDA-approved and marketed product, ZYNLONTA (loncastuximab tesirine), is a CD19-directed antibody and alkylating agent conjugate indicated for the treatment of adult patients with relapsed or refractory large B-cell lymphoma after two or more lines of systemic therapy. Additionally, the company's development pipeline comprises LOTIS-2, LOTIS-5, LOTIS-7, and ADCT-241, being developed as potential therapies for different cancer diseases. Geographically, the firm generates maximum revenue from the United States, followed by Europe, the Middle East and Africa (EMEA).

Share on Social Networks: